The short version

A peptide sold as “research use only” is sold as a lab chemical. The label says it is not for people. A laboratory purchase is not a prescription or a clinical evaluation.

A prescription requires a licensed provider to review a patient’s health and decide whether to prescribe. A prescription does not make a compounded peptide FDA-approved, does not change what the research shows, and does not by itself authorize every compounded preparation.

Same name, different route

Search for almost any popular peptide and two kinds of result come back. One is a product page from a research chemical seller. The other, less often, is a prescription service. Both may use exactly the same name, and in many cases they are describing the same molecule.

So the difference is not in the name. It is in everything around the name: who decided the peptide was appropriate, who prepared it and under which rules, what is printed on the label, and whether anyone can tell you it isn’t a good idea. That is what this page walks through.

What “research use only” means

“Research use only” is a sales category, not a quality grade. It describes a chemical sold for laboratory work, such as cell cultures, animal studies or analytical testing. The label on the vial usually says “not for human use”, and the seller’s terms usually say the same.

A research-use label does not establish that a product is suitable for people or exempt it from drug law. Regulatory status also depends on the product’s intended use and marketing. Instructions promoting human use may be evidence of intended human drug use despite a research label.

Research-use labeling does not establish that a purchaser has received a licensed clinician’s evaluation. A laboratory sale is not patient-specific medical care or a prescription decision.

None of this is hidden. The label means what it says: the product was never meant to come with a clinician attached.

What a prescription route means

A prescription starts with you rather than with a product. A licensed provider looks at your health information first: your history, the medicines you take and what you are hoping for. Each treatment has its own questions, because what matters before prescribing one peptide is not what matters for another.

Then the provider decides. They can prescribe or decline. Not everyone qualifies, and a provider saying no is part of what makes this route different from a checkout page.

If a provider prescribes and a pharmacy can fulfill the prescription, a licensed U.S. compounding pharmacy prepares the medicine for the named patient. FDA says state boards of pharmacy generally have primary responsibility for pharmacies’ day-to-day oversight.¹

Compounding has substance-specific and patient-specific requirements. A prescription alone does not authorize a pharmacy to prepare every peptide.

What a prescription doesn’t change

The limits are worth stating plainly, because they apply to every compounded peptide, however it is prescribed.

“Compounded drugs are not FDA-approved. This means that FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed.”
U.S. Food and Drug Administration, Compounding and the FDA: Questions and Answers

The research does not change either. For many peptides, most of the evidence comes from cell and animal studies, with little in people. A prescription is one clinician’s judgment about one person. It is not proof that a peptide works, which is why every page in the peptide library names the species each finding comes from.

And the rules around some peptides have shifted. FDA keeps lists that govern which bulk ingredients compounding pharmacies may use, and several well-known peptides have changed places on those lists since 2023. Each library page gives that peptide’s status as FDA’s own pages describe it.

Side by side

Research-only peptides compared with a prescription route
Question	Research-only	Prescription
Who it’s sold for	Laboratory research	You, by name
Patient-specific clinical review	Not established by a laboratory sale	Required before a prescribing decision
Medical prescribing decision	No prescription decision is part of a laboratory sale	A licensed provider may prescribe or decline
Who prepares it	Varies by seller	A licensed U.S. compounding pharmacy
The label	“Not for human use”	Your name and your provider’s instructions
Intended use	Laboratory research, not patient care	Patient care after clinical review
FDA approval	Not FDA-approved	Compounded medicines are not FDA-approved either

The last row is the same on both sides on purpose. The difference a prescription makes is the person reviewing your health, not a regulator’s approval.

Where Promise Peptides fits

Promise Peptides is currently taking waitlist sign-ups. Joining is not a medical request and no prescription comes from it. The planned service area is all 50 states and DC, but not every treatment is available in every state. Promise is LegitScript-certified.

Peak may earn money when readers become Promise patients.

Promise waitlist

Read Promise’s treatment information and view its waitlist. Visits are not currently open.

Join the Promise waitlist